Lee Zuckerman, MD
Surgical Oncology · Los Angeles, CANPI 1053565143
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $17,200 of the $19,135 with a category attached, or 89.9%. Nuvasive Specialized Orthopedics, Inc. accounts for 91.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $10,761 and has fallen 88.1% since, to $1,285 in 2025. Among surgical oncology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $445.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nuvasive Specialized Orthopedics, Inc.$18K
- Deciphera Pharmaceuticals Inc.$961
- Orthofix Medical, Inc.$350
- Onkos Surgical, Inc.$117
- Tempus AI, Inc$79
- Stryker$44
- plus $63 from 2 others
What the payments were for
- Consulting fees$17,20090%
- Speaking & faculty fees$7504%
- Travel & lodging$2811%
- Food & beverage$9055%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nuvasive Specialized Orthopedics, Inc. | 26 | $17,521 |
| Deciphera Pharmaceuticals Inc. | 5 | $961 |
| Orthofix Medical, Inc. | 5 | $350 |
| Onkos Surgical, Inc. | 1 | $117 |
| Tempus AI, Inc | 3 | $79 |
| Stryker | 1 | $44 |
| Globus Medical | 1 | $37 |
| Merck | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRECICE$9,650
- PRECICE Intramedullary Limb Lengthening System$3,500
- ROMVIMZA$750
- FITBONE$162
- QINLOCK$125
How this compares
$19,135 in reported general payments places this provider in the 90th percentile of 209 surgical oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Los Angeles
- Ronald HurstLos Angeles$76K
- James EconomouLos Angeles$27K
- Cristina FerroneLos Angeles$25K
- Scott UmLos Angeles$16K
- Lawrence MenendezLos Angeles$13K
- Sujit KulkarniLos Angeles$11K
- Mediget TeshomeLos Angeles$9K
- Joshua EllenhornLos Angeles$9K
- Jason CohenLos Angeles$8K
- Afshin BahadorSan Diego$701K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.